U.S. flag

An official website of the United States government

NM_013275.6(ANKRD11):c.2408_2412del (p.Lys803fs) AND Inborn genetic diseases

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Sep 28, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002519008.6

Allele description [Variation Report for NM_013275.6(ANKRD11):c.2408_2412del (p.Lys803fs)]

NM_013275.6(ANKRD11):c.2408_2412del (p.Lys803fs)

Gene:
ANKRD11:ankyrin repeat domain containing 11 [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
16q24.3
Genomic location:
Preferred name:
NM_013275.6(ANKRD11):c.2408_2412del (p.Lys803fs)
HGVS:
  • NC_000016.10:g.89284131_89284135del
  • NG_032003.2:g.211428_211432del
  • NM_001256182.2:c.2408_2412del
  • NM_001256183.2:c.2408_2412del
  • NM_013275.6:c.2408_2412delMANE SELECT
  • NP_001243111.1:p.Lys803fs
  • NP_001243112.1:p.Lys803fs
  • NP_037407.4:p.Lys803fs
  • NC_000016.9:g.89350538_89350542del
  • NC_000016.9:g.89350539_89350543del
  • NG_032003.1:g.211428_211432del
  • NM_001256182.1:c.2408_2412del
  • NM_001256182.2:c.2408_2412delAAAAA
  • NM_013275.4:c.2408_2412delAAAAA
  • NM_013275.5:c.2408_2412del
  • NM_013275.5:c.2408_2412del5
  • NM_013275.5:c.2408_2412delAAAAA
  • NM_013275.6:c.2408_2412delAAAAAMANE SELECT
Protein change:
K803fs
Links:
dbSNP: rs886039902
NCBI 1000 Genomes Browser:
rs886039902
Molecular consequence:
  • NM_001256182.2:c.2408_2412del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001256183.2:c.2408_2412del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_013275.6:c.2408_2412del - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
Inborn genetic diseases
Identifiers:
MeSH: D030342; MedGen: C0950123

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003636019Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Pathogenic
(Sep 28, 2022)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Clinical and genetic aspects of KBG syndrome.

Low K, Ashraf T, Canham N, Clayton-Smith J, Deshpande C, Donaldson A, Fisher R, Flinter F, Foulds N, Fryer A, Gibson K, Hayes I, Hills A, Holder S, Irving M, Joss S, Kivuva E, Lachlan K, Magee A, McConnell V, McEntagart M, Metcalfe K, et al.

Am J Med Genet A. 2016 Nov;170(11):2835-2846. doi: 10.1002/ajmg.a.37842. Epub 2016 Sep 26.

PubMed [citation]
PMID:
27667800
PMCID:
PMC5435101

KBG syndrome: Common and uncommon clinical features based on 31 new patients.

Gnazzo M, Lepri FR, Dentici ML, Capolino R, Pisaneschi E, Agolini E, Rinelli M, Alesi V, Versacci P, Genovese S, Cesario C, Sinibaldi L, Baban A, Bartuli A, Marino B, Cappa M, Dallapiccola B, Novelli A, Digilio MC.

Am J Med Genet A. 2020 May;182(5):1073-1083. doi: 10.1002/ajmg.a.61524. Epub 2020 Mar 3.

PubMed [citation]
PMID:
32124548
See all PubMed Citations (4)

Details of each submission

From Ambry Genetics, SCV003636019.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

The c.2408_2412delAAAAA (p.K803Rfs*5) alteration, located in exon 9 (coding exon 7) of the ANKRD11 gene, consists of a deletion of 5 nucleotides from position 2408 to 2412, causing a translational frameshift with a predicted alternate stop codon after 5 amino acids. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). This alteration has been reported as de novo in multiple unrelated individuals with clinical features of KBG syndrome (Parenti, 2021; Gnazzo, 2020). Additional heterozygous individuals with ANKRD11 variants have been reported in the literature (Low, 2016; Bestetti, 2022). Based on the available evidence, this alteration is classified as pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Dec 22, 2024